{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T02:33:03Z","timestamp":1784860383852,"version":"3.55.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,20]],"date-time":"2018-03-20T00:00:00Z","timestamp":1521504000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"BRAND\u2019S Brain Research Centre"},{"name":"General project and invention of Prince of Songkla University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Altern Med"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12906-018-2166-0","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T03:24:10Z","timestamp":1522812250000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["The antioxidant and neurochemical activity of Apium graveolens L. and its ameliorative effect on MPTP-induced Parkinson-like symptoms in mice"],"prefix":"10.1186","volume":"18","author":[{"given":"Pennapa","family":"Chonpathompikunlert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phetcharat","family":"Boonruamkaew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanida","family":"Sukketsiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilaiwanwadee","family":"Hutamekalin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8430-9600","authenticated-orcid":false,"given":"Morakot","family":"Sroyraya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,20]]},"reference":[{"key":"2166_CR1","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.ddmec.2004.11.016","volume":"1","author":"JL Eriksen","year":"2004","unstructured":"Eriksen JL, Petrucelli L. Parkinson\u2019s disease-molecular mechanisms of disease. Drug Discov Today Dis Mech. 2004;1:399\u2013405.","journal-title":"Drug Discov Today Dis Mech"},{"key":"2166_CR2","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1016\/S0140-6736(04)16305-8","volume":"363","author":"A Samii","year":"2004","unstructured":"Samii A, Nutt JG, Ransom BR. Parkinson's disease. Lancet. 2004;363:1783\u201393.","journal-title":"Lancet"},{"key":"2166_CR3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.pneurobio.2006.11.009","volume":"81","author":"N Singh","year":"2007","unstructured":"Singh N, Pillay V, Choonara YE. Advances in the treatment of Parkinson\u2019s disease. Prog Neurobiol. 2007;81:29\u201344.","journal-title":"Prog Neurobiol"},{"key":"2166_CR4","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/nrn983","volume":"3","author":"J Lotharius","year":"2002","unstructured":"Lotharius J, Brundin P. Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein. Nat Rev Neurosci. 2002;3:932\u201342.","journal-title":"Nat Rev Neurosci"},{"key":"2166_CR5","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1126\/science.1087753","volume":"302","author":"TM Dawson","year":"2003","unstructured":"Dawson TM, Dawson VL. Molecular pathways of neurodegeneration in Parkinson's disease. Science. 2003;302:819\u201322.","journal-title":"Science"},{"key":"2166_CR6","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1212\/WNL.50.3_Suppl_3.S1","volume":"50","author":"CW Olanow","year":"1998","unstructured":"Olanow CW, Koller WC. An algorithm (decision tree) for the management of Parkinson's disease: treatment guidelines. American academy of neurology. Neurology. 1998;50:S1\u201357.","journal-title":"Neurology"},{"key":"2166_CR7","first-page":"S22","volume":"47","author":"JA Obeso","year":"2000","unstructured":"Obeso JA, Rodriguez-Oroz MC, Rodriguez M, DeLong MR, Olanow CW. Pathophysiology of levodopa-induced dyskinesias in Parkinson's disease: problems with the current model. Ann Neurol. 2000;47:S22\u201332.","journal-title":"Ann Neurol"},{"key":"2166_CR8","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/j.1750-3639.2002.tb00468.x","volume":"12","author":"R Betarbet","year":"2002","unstructured":"Betarbet R, Sherer TB, Di Monte DA, Greenamyre JT. Mechanistic approaches to Parkinson's disease pathogenesis. Brain Pathol. 2002;12:499\u2013510.","journal-title":"Brain Pathol"},{"key":"2166_CR9","doi-asserted-by":"publisher","first-page":"105","DOI":"10.7754\/Clin.Lab.2015.150538","volume":"62","author":"A Bolner","year":"2016","unstructured":"Bolner A, Micciolo R, Bosello O, Nordera GP. A panel of oxidative stress markers in Parkinson's disease. Clin Lab. 2016;62:105\u201312.","journal-title":"Clin Lab"},{"key":"2166_CR10","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1089\/ars.2011.4019","volume":"16","author":"MK McCoy","year":"2012","unstructured":"McCoy MK, Cookson MR. Mitochondrial quality control and dynamics in Parkinson's disease. Antioxid Redox Signal. 2012;16:869\u201382.","journal-title":"Antioxid Redox Signal"},{"key":"2166_CR11","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/978-3-211-33328-0_7","volume":"71","author":"T Nagatsu","year":"2006","unstructured":"Nagatsu T, Sawada M. Molecular mechanism of the relation of monoamine oxidase B and its inhibitors to Parkinson's disease: possible implications of glial cells. J Neural Transm Suppl. 2006;71:53\u201365.","journal-title":"J Neural Transm Suppl"},{"key":"2166_CR12","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1006\/bbrc.2000.2232","volume":"268","author":"J Boada","year":"2000","unstructured":"Boada J, Cutillas B, Roig T, Berm\u00fadez J, Ambrosio S. MPP(+)-induced mitochondrial dysfunction is potentiated by dopamine. Biochem Biophys Res Commun. 2000;268:916\u201320.","journal-title":"Biochem Biophys Res Commun"},{"key":"2166_CR13","doi-asserted-by":"publisher","first-page":"327","DOI":"10.2174\/156720506778249515","volume":"3","author":"KP Loh","year":"2006","unstructured":"Loh KP, Huang SH, De Silva R, Tan H, Benny K, Zhun Zhu Y. Oxidative stress: apoptosis in neuronal injury. Curr Alzheimer Res. 2006;3:327\u201337.","journal-title":"Curr Alzheimer Res"},{"key":"2166_CR14","first-page":"157","volume":"60","author":"N Shibata","year":"2008","unstructured":"Shibata N, Kobayashi M. The role for oxidative stress in neurodegenerative diseases. Brain Nerve. 2008;60:157\u201370.","journal-title":"Brain Nerve"},{"issue":"1","key":"2166_CR15","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/1423-0127-16-98","volume":"16","author":"Y Liu","year":"2009","unstructured":"Liu Y, Schubert DR. The specificity of neuroprotection by antioxidants. J Biomed Sci. 2009;16(1):98.","journal-title":"J Biomed Sci"},{"key":"2166_CR16","first-page":"37","volume":"89","author":"JA Borovac","year":"2016","unstructured":"Borovac JA. Side effects of a dopamine agonist therapy for Parkinson\u2019s disease: a mini-review of clinical pharmacology. Yale J Biol Med. 2016;89:37\u201347.","journal-title":"Yale J Biol Med"},{"key":"2166_CR17","doi-asserted-by":"publisher","first-page":"154","DOI":"10.2337\/diaspect.14.3.154","volume":"14","author":"MB Covington","year":"2001","unstructured":"Covington MB. Traditional chinese medicine in the treatment of diabetes. Diabetes Spectr. 2001;14:154\u20139.","journal-title":"Diabetes Spectr"},{"key":"2166_CR18","first-page":"152","volume":"12","author":"GH Tong","year":"2008","unstructured":"Tong GH, Zhang Y, Zhang YN, Li H, Liu J. Effect of celery seed extract on hyperuricemia in rats. Food Sci. 2008;12:152.","journal-title":"Food Sci"},{"key":"2166_CR19","doi-asserted-by":"crossref","first-page":"36","DOI":"10.35652\/IGJPS.2012.03","volume":"2","author":"SF Syed","year":"2012","unstructured":"Syed SF, Rajeev KS. Review on the pharmacognostical & pharmacological characterization of Apium Graveolens Linn. IGJPS. 2012;2:36\u201342.","journal-title":"IGJPS"},{"key":"2166_CR20","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s11741-006-0111-9","volume":"10","author":"TQ Wen","year":"2006","unstructured":"Wen TQ, Lu W, Chen FX, Song HS, Zhao CP, Yu T. Apium graveolens L. accelerating differentiation of neural stem cells in vitro. J Shanghai Univ. 2006;10:89\u201394.","journal-title":"J Shanghai Univ"},{"key":"2166_CR21","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1517\/13543770902721279","volume":"19","author":"P Taupin","year":"2009","unstructured":"Taupin P. Apigenin and related compounds stimulate adult neurogenesis. Expert Opin Ther Pat. 2009;19:523\u20137.","journal-title":"Expert Opin Ther Pat"},{"key":"2166_CR22","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.neulet.2008.10.046","volume":"448","author":"HQ Chen","year":"2008","unstructured":"Chen HQ, Jin ZY, Wang XJ, Xu XM, Deng L, Zhao JW. Luteolin protects dopaminergic neurons from inflammation-induced injury through inhibition of microglial activation. Neurosci Lett. 2008;448:175\u20139.","journal-title":"Neurosci Lett"},{"key":"2166_CR23","doi-asserted-by":"publisher","first-page":"e12276","DOI":"10.1111\/jfbc.12276","volume":"41","author":"N Choosri","year":"2017","unstructured":"Choosri N, Tanasawet S, Chonpathompikunlert P, Sukketsiri W. Apium Graveolens extract attenuates adjuvant induced arthritis by reducing oxidative stress. J Food Biochem. 2017;41:e12276.","journal-title":"J Food Biochem"},{"key":"2166_CR24","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1007\/s11418-017-1077-6","volume":"71","author":"P Boonruamkaew","year":"2017","unstructured":"Boonruamkaew P, Sukketsiri W, Panichayupakaranant P, Kaewnam W, Tanasawet S, Tipmanee V, Hutamekalin P, Chonpathompikunlert P. Apium graveolens extract influences mood and cognition in healthy mice. J Nat Med. 2017;71:492\u2013505.","journal-title":"J Nat Med"},{"issue":"8","key":"2166_CR25","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1248\/bpb.b14-00128","volume":"37","author":"G Feng","year":"2014","unstructured":"Feng G, Zhang Z, Bao Q, Zhang Z, Zhou L, Jiang J, Li S. Protective effect of chinonin in MPTP-induced C57BL\/6 mouse model of Parkinson\u2019s disease. Biol Pharm Bull. 2014;37(8):1301\u20137.","journal-title":"Biol Pharm Bull"},{"key":"2166_CR26","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1023\/A:1001958023096","volume":"30","author":"M Sedelis","year":"2000","unstructured":"Sedelis M, Hofele K, Auburger GW, Morgan S, Huston JP, Schwarting RKMPTP. Susceptibility in the mouse: behavioral, neurochemical, and histological analysis of gender and strain differences. Behav Genet. 2000;30:171\u201382.","journal-title":"Behav Genet"},{"key":"2166_CR27","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S1385-299X(97)00034-2","volume":"2","author":"G Rozas","year":"1997","unstructured":"Rozas G, Guerra MJ, Labandeira-Garc\u0131\u0301a JL. An automated rotarod method for quantitative drug-free evaluation of overall motor deficits in rat models of parkinsonism. Brain Res Brian Res Protoc. 1997;2:75\u201384.","journal-title":"Brain Res Brian Res Protoc"},{"key":"2166_CR28","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/0278-5846(88)90038-3","volume":"12","author":"M Pisa","year":"1998","unstructured":"Pisa M. Regional specialization of motor functions in the rat striatum: implications for the treatment of parkinsonism. Prog Neuro-Psychopharmacol Biol Psychiatry. 1998;12:217\u201324.","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"2166_CR29","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.nbd.2008.02.011","volume":"30","author":"R Viaro","year":"2008","unstructured":"Viaro R, Sanchez-Pernaute R, Marti M, Trapella C, Isacson O, Morari M. Nociceptin\/orphanin FQ receptor blockade attenuates MPTP-induced parkinsonism. Neurobiol Dis. 2008;30:430\u20138.","journal-title":"Neurobiol Dis"},{"key":"2166_CR30","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0165-0270(02)00360-6","volume":"123","author":"JL Tillerson","year":"2003","unstructured":"Tillerson JL, Miller GW. Grid performance test to measure behavioral impairment in the MPTP-treated-mouse model of parkinsonism. J Neurosci Methods. 2003;123:189\u2013200.","journal-title":"J Neurosci Methods"},{"key":"2166_CR31","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.bbr.2005.04.011","volume":"163","author":"R Haobam","year":"2005","unstructured":"Haobam R, Sindhu KM, Chandra G, Mohanakumar KP. Swim-test as a function of motor impairment in MPTP model of Parkinson's disease: a comparative study in two mouse strains. Behav Brain Res. 2005;163:159\u201367.","journal-title":"Behav Brain Res"},{"key":"2166_CR32","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.nbd.2004.01.007","volume":"16","author":"M Lundblad","year":"2004","unstructured":"Lundblad M, Picconi B, Lindgren H, Cenci MA. A model of L-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function. Neurobiol Dis. 2004;16:110\u201323.","journal-title":"Neurobiol Dis"},{"key":"2166_CR33","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1006\/abio.1996.9911","volume":"244","author":"A Holt","year":"1997","unstructured":"Holt A, Sharman DF, Baker GB, Palcic MM. A continuous spectrophotometric assay for monoamine oxidase and related enzymes in tissue homogenates. Anal Biochem. 1997;244:384\u201392.","journal-title":"Anal Biochem"},{"key":"2166_CR34","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","volume":"95","author":"H Ohkawa","year":"1979","unstructured":"Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95:351\u20138.","journal-title":"Anal Biochem"},{"key":"2166_CR35","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265\u201375.","journal-title":"J Biol Chem"},{"key":"2166_CR36","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/0736-5748(95)00071-2","volume":"13","author":"S Hussain","year":"1995","unstructured":"Hussain S, WJr S, Ali SF. Age-related changes in antioxidant enzymes, superoxide dismutase, catalase, glutathione peroxidase and glutathione in different regions of mouse brain. Int J Dev Neurosci. 1995;13:811\u20137.","journal-title":"Int J Dev Neurosci"},{"key":"2166_CR37","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1006\/abio.1997.2273","volume":"251","author":"H Ukeda","year":"1997","unstructured":"Ukeda H, Maeda S, Ishii T, Sawamura M. Spectrophotometric assay for superoxide dismutase based on tetrazolium salt 3\u2032-{1-[(phenylamino)-carbonyl]-3,4-tetrazolium}-bis(4-methoxy-6-nitro) benzenesulfonic acid hydrate reduction by xanthine-xanthine oxidase. Anal Biochem. 1997;251:206\u20139.","journal-title":"Anal Biochem"},{"key":"2166_CR38","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1191\/0960327105ht509oa","volume":"24","author":"M Ahmad","year":"2005","unstructured":"Ahmad M, Saleem S, Ahmad AS, Ansari MA, Yousuf S, Hoda MN, Islam F. Neuroprotective effects of Withania somnifera on 6-hydroxydopamine induced parkinsonism in rats. Hum Exp Toxicol. 2005;24:137\u201347.","journal-title":"Hum Exp Toxicol"},{"key":"2166_CR39","volume-title":"Academic Press","author":"G Paxinos","year":"2012","unstructured":"Paxinos G, Franklin K. Paxinos and Franklin\u2019s the mouse brain in stereotaxic coordinates. 4th ed. In: Academic Press; 2012."},{"key":"2166_CR40","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.neuroscience.2014.10.037","volume":"284","author":"E Dragicevic","year":"2015","unstructured":"Dragicevic E, Schiemann J, Liss B. Dopamine midbrain neurons in health and Parkinson's disease: emerging roles of voltage-gated calcium channels and ATP-sensitive potassium channels. Neuroscience. 2015;284:798\u2013814.","journal-title":"Neuroscience"},{"key":"2166_CR41","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S0306-4522(02)00401-3","volume":"115","author":"I Ghorayeb","year":"2002","unstructured":"Ghorayeb I, Fernagut PO, Hervier L, Labattu B, Bioulac B, Tison FA. Single toxin-double lesion' rat model of striatonigral degeneration by intrastriatal 1-methyl-4-phenylpyridinium ion injection: a motor behavioural analysis. Neuroscience. 2002;115:533\u201346.","journal-title":"Neuroscience"},{"key":"2166_CR42","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1046\/j.1440-1681.2003.03922.x","volume":"30","author":"JM Henderson","year":"2003","unstructured":"Henderson JM. Experimental therapeutics of Parkinson's disease. Clin Exp Pharmacol Physiol. 2003;30:841\u20134.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"2166_CR43","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/S1353-8020(09)70004-5","volume":"15","author":"T Nagatsua","year":"2009","unstructured":"Nagatsua T, Sawadab M. L-dopa therapy for Parkinson's disease: past, present, and future. Parkinsonism Relat Disord. 2009;15:S3\u20138.","journal-title":"Parkinsonism Relat Disord"},{"key":"2166_CR44","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1602\/neurorx.1.1.139","volume":"1","author":"S Fahn","year":"2004","unstructured":"Fahn S, Sulzer D. Neurodegeneration and neuroprotection in Parkinson disease. NeuroRx. 2004;1:139\u201354.","journal-title":"NeuroRx"},{"key":"2166_CR45","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.tins.2008.02.010","volume":"31","author":"WM Caudle","year":"2008","unstructured":"Caudle WM, Colebrooke RE, Emson PC, Miller GW. Altered vesicular dopamine storage in Parkinson's disease: a premature demise. Trends Neurosci. 2008;31:303\u20138.","journal-title":"Trends Neurosci"},{"key":"2166_CR46","doi-asserted-by":"publisher","first-page":"167","DOI":"10.2174\/156720212801618956","volume":"9","author":"L Zhang","year":"2012","unstructured":"Zhang L, Yu WH, Wang C, Zhao F, Qi W, Chan W, Huang Y, SM Wai M, Dong J, T Yew D. DL-3-n-butylphthalide, an anti-oxidant agent, prevents neurological deficits and cerebral injury following stroke per functional analysis, magnetic resonance imaging and histological assessment. Curr Neurovasc Res. 2012;9:167\u201375.","journal-title":"Curr Neurovasc Res"},{"key":"2166_CR47","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1007\/s007020100004","volume":"108","author":"N Schmidt","year":"2001","unstructured":"Schmidt N, Ferger B. Neurochemical findings in the MPTP model of Parkinson's disease. J Neural Transm (Vienna). 2001;108:1263\u201382.","journal-title":"J Neural Transm (Vienna)"},{"key":"2166_CR48","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s00441-004-0938-y","volume":"318","author":"A Schober","year":"2004","unstructured":"Schober A. Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP. Cell Tissue Res. 2004;318:215\u201324.","journal-title":"Cell Tissue Res"},{"key":"2166_CR49","doi-asserted-by":"publisher","unstructured":"Miville-Godbout E, Bourque M, Morissette M, Al-Sweidi S, Smith T, Mochizuki A, Senanayake V, Jayasinghe D, Wang L, Goodenowe D, Di Paolo T. Plasmalogen augmentation reverses striatal dopamine loss in MPTP mice. PLoS One. 2016;11. https:\/\/doi.org\/10.1371\/journal.pone.0151020 .","DOI":"10.1371\/journal.pone.0151020"},{"key":"2166_CR50","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.neuroscience.2015.09.065","volume":"312","author":"SK Franke","year":"2016","unstructured":"Franke SK, Kesteren RE, Wubben JA, Hofman S, Paliukhovich I, Van Der Schors RC, Van Nierop P, Smit AB, Philippens IH. Progression and recovery of parkinsonism in a chronic progressive MPTP-induction model in the marmoset without persistent molecular and cellular damage. Neuroscience. 2016;312:247\u201359.","journal-title":"Neuroscience"},{"key":"2166_CR51","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.apjtb.2016.11.003","volume":"7","author":"S Tanasawet","year":"2017","unstructured":"Tanasawet S, Boonruamkaew P, Sukketsiri W, Chonpathompikunlert P. Anxiolytic and free radical scavenging potential of Chinese celery (Apium graveolens) extract in mice. Asian Pac J Trop Biomed. 2017;7:20\u20136.","journal-title":"Asian Pac J Trop Biomed"},{"key":"2166_CR52","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.1749-6632.1999.tb08007.x","volume":"890","author":"CC Chiueh","year":"1999","unstructured":"Chiueh CC. Neuroprotective properties of nitric oxide. Ann N Y Acad Sci. 1999;890:301\u201311.","journal-title":"Ann N Y Acad Sci"},{"key":"2166_CR53","doi-asserted-by":"publisher","unstructured":"Zhu T, Park HE, Row KH. Purification of luteolin and apigenin from celery leaves using hybrid organic-inorganic monolithic cartridge. J Liq Chromatogr Relat Technol. 2014;37. https:\/\/doi.org\/10.1080\/10826076.2013.825848 .","DOI":"10.1080\/10826076.2013.825848"}],"container-title":["BMC Complementary and Alternative Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-018-2166-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12906-018-2166-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-018-2166-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T22:35:26Z","timestamp":1693607726000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-018-2166-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,20]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2166"],"URL":"https:\/\/doi.org\/10.1186\/s12906-018-2166-0","relation":{},"ISSN":["1472-6882"],"issn-type":[{"value":"1472-6882","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,20]]},"assertion":[{"value":"30 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the Animal Ethics Committee of Prince of Songkla University (Reference no. MOE0521.11\/582) before the start of this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All authors signed the paper and agreed to publish it.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"103"}}